These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1154 related articles for article (PubMed ID: 22398146)

  • 1. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
    Semenza GL
    Trends Pharmacol Sci; 2012 Apr; 33(4):207-14. PubMed ID: 22398146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia inducible factor pathway inhibitors as anticancer therapeutics.
    Burroughs SK; Kaluz S; Wang D; Wang K; Van Meir EG; Wang B
    Future Med Chem; 2013 Apr; 5(5):553-72. PubMed ID: 23573973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.
    Schito L; Semenza GL
    Trends Cancer; 2016 Dec; 2(12):758-770. PubMed ID: 28741521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting hypoxia for sensitization of tumors to radio- and chemotherapy.
    Ghattass K; Assah R; El-Sabban M; Gali-Muhtasib H
    Curr Cancer Drug Targets; 2013 Jul; 13(6):670-85. PubMed ID: 23687923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy.
    Albadari N; Deng S; Li W
    Expert Opin Drug Discov; 2019 Jul; 14(7):667-682. PubMed ID: 31070059
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of HIF-1 inhibitors for cancer therapy.
    Onnis B; Rapisarda A; Melillo G
    J Cell Mol Med; 2009 Sep; 13(9A):2780-6. PubMed ID: 19674190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF repressors under chronic hypoxia.
    Luo W; Wang Y
    Aging (Albany NY); 2016 Mar; 8(3):418-9. PubMed ID: 26954058
    [No Abstract]   [Full Text] [Related]  

  • 8. HIF-1 inhibitors for cancer therapy: from gene expression to drug discovery.
    Semenza GL
    Curr Pharm Des; 2009; 15(33):3839-43. PubMed ID: 19671047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors.
    Xia Y; Choi HK; Lee K
    Eur J Med Chem; 2012 Mar; 49():24-40. PubMed ID: 22305612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer.
    Agani F; Jiang BH
    Curr Cancer Drug Targets; 2013 Mar; 13(3):245-51. PubMed ID: 23297826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.
    Wigerup C; Påhlman S; Bexell D
    Pharmacol Ther; 2016 Aug; 164():152-69. PubMed ID: 27139518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer therapeutic agents targeting hypoxia-inducible factor-1.
    Wang R; Zhou S; Li S
    Curr Med Chem; 2011; 18(21):3168-89. PubMed ID: 21671859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer therapy by targeting hypoxia-inducible factor-1.
    Li Y; Ye D
    Curr Cancer Drug Targets; 2010 Nov; 10(7):782-96. PubMed ID: 20578983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and structure-activity relationships of 1-ethylpyrazole-3-carboxamide compounds as novel hypoxia-inducible factor (HIF)-1 inhibitors.
    Yasuda Y; Arakawa T; Nawata Y; Shimada S; Oishi S; Fujii N; Nishimura S; Hattori A; Kakeya H
    Bioorg Med Chem; 2015 Apr; 23(8):1776-87. PubMed ID: 25773014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hypoxia inducible factor-1 in cell metabolism--a possible target in cancer therapy.
    Bel Aiba RS; Dimova EY; Görlach A; Kietzmann T
    Expert Opin Ther Targets; 2006 Aug; 10(4):583-99. PubMed ID: 16848694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part II.
    Wilczynski J; Duechler M; Czyz M
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):301-7. PubMed ID: 21625847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of HIF-1 inhibitors as anticancer agents.
    Semenza GL
    Drug Discov Today; 2007 Oct; 12(19-20):853-9. PubMed ID: 17933687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting hypoxia-inducible factor 1 (HIF-1) signaling with natural products toward cancer chemotherapy.
    Ikeda H; Kakeya H
    J Antibiot (Tokyo); 2021 Oct; 74(10):687-695. PubMed ID: 34331027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 58.